Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Pharmacokinetics

Interventions

DRUG

Naproxen Sodium, (BAY H6689)

One dose of Naproxen sodium extended release 660 mg under fasting conditions

DRUG

Naprelan, (BAY H6689)

One dose of Naprelan 500 mg (2 tablets) under fasting conditions

Trial Locations (1)

Austin